Dividend Overview
Dividend Yield
1.95%
Dividend / Share
$2.94
3M Company
3M Company (3M) is a diversified technology company. The Company operates in six segments: industrial and transportation; healthcare; consumer and office; safety, security and protection services; display and graphics, and electro and communications businesses. 3M products are sold through a number of distribution channels, including directly to users and through wholesalers, retailers, jobbers, distributors and dealers in a range of trades in a number of countries worldwide. In April 2012, it acquired CodeRyte Inc. In September 2012, it acquired the business of Federal Signal Technologies Group (FSTech) from Federal Signal Corporation. On November 28, 2012, the Company acquired Ceradyne, Inc.
Capital expenditures decreased by 27% from FY24 to FY25.
Current Price
$150.50
+0.89%GoodMoat Value
$77.66
48.4% overvalued3M's dividend profile is unfavourable for an income-focused value investor. The dividend appears unsustainable due to a high payout ratio and weak free cash flow generation, while a heavy debt burden adds significant risk to the dividend's long-term security.
Dividend Yield
1.95%
Dividend / Share
$2.94
Market Cap
$79.95B
P/E Ratio
24.60
Forward P/E
—
EPS
$6.00
PEG Ratio
-1.23
Book Value
$8.85
Dividend Yield
1.95%
Profit Margin
13.03%
ROE
69.12%
3M Company (MMM) dividend analysis including yield, payout history, and sustainability metrics. The current dividend yield is 1.95%. The annual dividend per share is $2.94.
P/E ratio: 24.60. Profit margin: 13.03%. Free cash flow: $1.49B. This page shows 3M Company's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported 3M Company's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.